Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies Read more
Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer Read more
Imbrium and TetraGenetics Announce Strategic Research Collaboration and License Option to Develop Novel Biologic Therapeutics for Pain Read more
Selexis SA and Turgut Expand Biosimilar Development Relationship by Signing Two Commercial License Agreements Read more